Production for the Whole World
In line with its corporate mission, the major goal of Helba İlaç is to carry its products and operations developed for health to the global scale successfully by maintaining in international markets. With this strategy, Helba İlaç establishes long-term collaborations with highly reliable business partners in the sector.
Helba İlaç sells its own products with its own sales and marketing organizations at the key markets such as Azerbaijan, Georgia, Kazakhstan, Kirgizia, Moldova, Uzbekistan, Tajikistan and Turkmenistan. It is a reliable player on a global scale by continuously increasing the number of licensed products along with new products added to its portfolio.
As of today, Helba İlaç has 254 licensed products (65 in Turkey, including 189 in other countries) in international markets and 350 employees worldwide. The number of licensed products will increase even further with the products that will receive new authorization, of which the R&D studies are ongoing and are about to be added to the portfolio.
Export to 17+ Countries
Helba İlaç made its first export to Azerbaijan in 2012. In the following years, the number of countries for export will be performed increased to 20 countries, including the strategically important Caucasus, the Commonwealth of Independent States, the Middle East and the Balkans.
We Produce for Global Brands
As required by its global collaboration strategy, Helba İlaç increases its contribution to human health by increasing its strength in the sector with new final product dosage forms, new authorization files, technology transfers, joint marketing and contract manufacturing agreements for foreign companies.
- Russian Federation
- Bosnia and Herzegovina
Helba İlaç has adopted the aim of increasing its service quality both domestically and internationally by adding new products to its portfolio in order to continue its services to the extent that it gives human health. For this purpose, it researches, evaluates and develops in-licensing, out-licensing, co-marketing and contract manufacturing opportunities. Helba İlaç will continue its innovative and pioneering identity further by evaluating national and international collaborations and all models.
Helba İlaç will continue its growth and development, which has identified its company vision and culture, with new business agreements in accordance with its strategic decisions and plans in near future.